Literature DB >> 11901147

Structural analysis of the extracellular domain of vaccinia virus envelope protein, A27L, by NMR and CD spectroscopy.

Ta-Hsien Lin1, Chih-Ming Chia, Jye-Chian Hsiao, Wen Chang, Chiao-Chu Ku, Shang-Cheng Hung, Der-Lii M Tzou.   

Abstract

This study presents the molecular structure of the extracellular domain of vaccinia virus envelope protein, A27L, determined by NMR and CD spectroscopy. A recombinant protein, eA27L-aa, containing this domain in which cysteines 71 and 72 were replaced with alanine, was constructed to prevent self-assembly due to intermolecular disulfide bonds between these two cysteines. The soluble eA27L-aa protein forms an oligomer resembling that of A27L on vaccinia virions. Heteronuclear correlation NMR spectroscopy was carried out on eA27L-aa in the presence or absence of urea to determine backbone resonance assignments. Chemical shift index (CSI) propensity analysis showed that eA27L-aa has two distinct structural domains, a relatively flexible 22-amino acid random coil in the N-terminal region and a fairly rigid alpha-helix structure in the remainder of the structure. Binding interaction studies using isothermal titration calorimetry suggest that a 12-amino acid lysine/arginine-rich segment in the N-terminal region is responsible for glycosaminoglycan binding. The rigid alpha-helix portion of eA27L-aa is probably involved in the intrinsic self-assembly, and CSI propensity analysis suggests that region N37-E49, with a residual alpha-helix tendency, is probably the self-assembly core. Self-assembly was ascribed to three hydrophobic leucine residues (Leu(41), Leu(45), and Leu(48)) in this segment. The folding mechanism of eA27L-aa was analyzed by CD spectroscopy, which revealed a two-step transition with a Gibbs free energy of 2.5 kcal/mol in the absence of urea. Based on these NMR and CD studies, a residue-specific molecular model of the extracellular domain of A27L is proposed. These studies on the molecular structure of eA27L-aa will help in understanding how vaccinia virus enters cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11901147     DOI: 10.1074/jbc.M110403200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  NMR assignment of the vaccinia virus envelope protein A27L.

Authors:  Feng-I Chu; Yu Ho; Der-Lii M Tzou
Journal:  J Biomol NMR       Date:  2005-06       Impact factor: 2.835

2.  Vaccinia viral protein A27 is anchored to the viral membrane via a cooperative interaction with viral membrane protein A17.

Authors:  Da-Rong Wang; Jye-Chian Hsiao; Chien-Hsuan Wong; Guo-Chian Li; Su-Ching Lin; Steve S-F Yu; Wenlung Chen; Wen Chang; Der-Lii M Tzou
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

3.  Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge.

Authors:  Christiana N Fogg; Jeffrey L Americo; Patricia L Earl; Wolfgang Resch; Lydia Aldaz-Carroll; Roselyn J Eisenberg; Gary H Cohen; Bernard Moss
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

4.  A turn-like structure "KKPE" segment mediates the specific binding of viral protein A27 to heparin and heparan sulfate on cell surfaces.

Authors:  Ping-Chen Shih; Min-Shiang Yang; Su-Ching Lin; Yu Ho; Jye-Chian Hsiao; Da-Rong Wang; Steve S-F Yu; Wen Chang; Der-Lii M Tzou
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

5.  Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycans.

Authors:  Chwan Hong Foo; Huan Lou; J Charles Whitbeck; Manuel Ponce-de-León; Doina Atanasiu; Roselyn J Eisenberg; Gary H Cohen
Journal:  Virology       Date:  2009-01-21       Impact factor: 3.616

6.  Crystal structure of vaccinia viral A27 protein reveals a novel structure critical for its function and complex formation with A26 protein.

Authors:  Tao-Hsin Chang; Shu-Jung Chang; Fu-Lien Hsieh; Tzu-Ping Ko; Cheng-Tse Lin; Meng-Ru Ho; Iren Wang; Shang-Te Danny Hsu; Rey-Ting Guo; Wen Chang; Andrew H J Wang
Journal:  PLoS Pathog       Date:  2013-08-22       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.